New York Bill Would Decriminalize Psilocybin
Proposed legislation in the state of New York would decriminalize psilocybin, the psychedelic compound in some types of mushrooms.
Proposed legislation in the state of New York would decriminalize psilocybin, the psychedelic compound in some types of mushrooms.
UK venture capital fund The Conscious Fund is working to make psychedelics more accessible and functional in various capacities.
After voters approved a measure that decriminalized psychedelics in Washington D.C. last November, the measure is now in effect.
In this episode of the Psychedelic Spotlight podcast we speak with Joël Brierre who is the founder & CEO of Kaivalya Kollectiv.
As we continue to strive to be the leading source for news and unique perspective within the emerging sector of medicinal psychedelics, we are excited to debut the Spotlight Roundup! This video series, produced in collaboration with Elk’s Pride Pictures, provides a concise and informative roundup related to some of the most important news developments happening within this rapidly expanding industry. From the latest IPO’s, to new clinical trials, the Spotlight Roundup covers everything you need to know!
Silo Wellness Inc., a wellness company in the psychedelics and functional mushroom space, is offering ketamine-assisted psychedelics wellness retreats
Awakn Life Sciences is looking at psychedelics for addiction, namely MDMA and ketamine for alcohol use disorder.
Hey guys! Today’s episode of “Could This DMT Company Break Through the Addiction Market?” is a little bit different. We’ll cover a DMT company called Entheon BioMedical Corp, ticker symbol ENBI on the CSE and ENTBF on the OTC market.
Entheon is a company trying to solve addiction through the use of DMT which is why I’ve had my eye on for a while now.
Anyone who has learned anything about DMT knows how interesting this compound is and how much healing potential it may have. DMT is especially interesting to me because of the fact that it is naturally produced in our bodies and because of the anecdotal evidence surrounding its mystical capabilities.
I’ve mentioned that an other videos but I’ll say it again. It was actually through learning about DMT on the Joe Rogan Podcast that launched my interest into the healing potential of psychedelics in general. Specifically, his podcasts with Dennis McKenna were an eye opener that I can genuinely say changed my life, because it led to the creation of this channel.
And one of the reasons I agreed to do this sponsored content was because when doing my research into Entheon, I learned that none other than Dennis McKenna was on the Scientific advisory board of the company, which gave me a boost in confidence.
So in this video we are going to do four things:
First give you a brief rundown on who Entheon is, the investment thesis, and the people behind the company.
Second we are going to take you into the realm of DMT, where we will discuss what DMT even is, people’s experiences on the drug, and the scientific literature that is making the potential for using DMT for healing so exciting.
Third, we will discuss Entheon’s upcoming Clinical trials testing the effectiveness of using DMT to treat addiction.
MindMed (MMED) is also doing clinical trials with DMT so I’m excited to see the results. What do you guys think? Is DMT a better alternative than ibogaine to treat addiction?
I hope you guys found some value in this and I’ll keep you posted for more changes!
Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
Follow us on social media! 🙌
Instagram: @psychedelicinvestor
Facebook: @thepsychedelicinvestor
email: thepsychedelicinvestor@gmail.com
Music: www.bensound.com
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.
The Psychedelic Investor was compensated $1,000 by Future Money Trends for the making of this video on Entheon Biomedical. James (The Psychedelic Investor) does not own a position in Entheon Biomedical and will not open one for at least 30 days after publication of this video.
https://entheonbiomedical.com/
CSE: ENBI | OTCQB: ENTBF
This video was conducted on behalf of Entheon Biomedical, and was funded by Gold Standard Media LLC. For our full disclaimer, please visit: https://www.goldstandardir.com/entheon-biomedical-disclaimer-85/
#MindMed #Entheon #PsychedelicStocks
Small Pharma is going into clinical trials to look at DMT for depression relief. The UK company says it believes benefits will be immediate.
Vermont is looking to decriminalize psychedelics as part of its efforts to improve public health in the state.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.